Gene signatures differentiate clinical response
New mRCC medication regimen effective and well tolerated
Positive results point to a better prognosis for intractable disease
Study examines concordance between commercially available genomic tests
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Survival for months or several years while delaying treatment is possible
Advertisement
Advertisement